CD4 News and Research

RSS
Major trends in AIDS research that the different research teams throughout the world are pursuing

Major trends in AIDS research that the different research teams throughout the world are pursuing

Solid evidence that best treatment for multiple sclerosis is pregnancy

Solid evidence that best treatment for multiple sclerosis is pregnancy

FDA reinforces use of Sustiva in first-line HIV combination therapy

FDA reinforces use of Sustiva in first-line HIV combination therapy

Genmab's HuMax-CD4 receives U.S. orphan drug designation

Genmab's HuMax-CD4 receives U.S. orphan drug designation

South Africa will continue providing Nevirapine as monotherapy to mothers and babies

South Africa will continue providing Nevirapine as monotherapy to mothers and babies

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new vaccine that may delay cancer recurrence

A new vaccine that may delay cancer recurrence

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

A new protocol for bone marrow transplants

A new protocol for bone marrow transplants

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Women delay AIDS with vitamins B, C and E

Women delay AIDS with vitamins B, C and E

Discovery may explain why people with AIDS may suffer severe infections from viruses that they would otherwise defeat

Discovery may explain why people with AIDS may suffer severe infections from viruses that they would otherwise defeat

Hair cloning could be the cure for baldness

Hair cloning could be the cure for baldness

Mothers infected with HIV who breast feed risk infecting infants

Mothers infected with HIV who breast feed risk infecting infants

Possible new second-generation multiple sclerosis therapy

Possible new second-generation multiple sclerosis therapy